NCT04297709View on ClinicalTrials.gov

Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Cystic Fibrosis
Trial Locations (1)

B9 5SS

Birmingham Heartlands Hospital, Birmingham

Sponsors

Lead Sponsor

Mologic Ltd
All Listed Sponsors
collaborator

Heart of England NHS Foundation Trust

UNKNOWN

lead

Mologic Ltd

INDUSTRY

NCT04297709 - Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis | Biotech Hunter | Biotech Hunter